These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

783 related items for PubMed ID: 20876319

  • 1. Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney.
    Basnayake K, Cheung CK, Sheaff M, Fuggle W, Kamel D, Nakoinz S, Hutchison CA, Cook M, Stoves J, Bradwell AR, Cockwell P.
    J Clin Pathol; 2010 Oct; 63(10):884-7. PubMed ID: 20876319
    [Abstract] [Full Text] [Related]

  • 2. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
    Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D.
    Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
    [Abstract] [Full Text] [Related]

  • 3. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
    Peters NO, Laurain E, Cridlig J, Hulin C, Cao-Huu T, Frimat L.
    Hemodial Int; 2011 Oct; 15(4):538-45. PubMed ID: 22111823
    [Abstract] [Full Text] [Related]

  • 4. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
    Borrego-Hinojosa J, Pérez-del Barrio MP, Biechy-Baldan Mdel M, Merino-García E, Sánchez-Perales MC, García-Cortés MJ, Ocaña-Pérez E, Gutiérrez-Rivas P, Liébana-Cañada A.
    Nefrologia; 2013 Oct; 33(4):515-23. PubMed ID: 23897183
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, Nabeshima K, Nakai S, Kato M, Ohashi A, Arai J, Hiki Y, Ishii J, Emi N, Sugiyama S, Yuzawa Y.
    Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
    [Abstract] [Full Text] [Related]

  • 6. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.
    Martín-Reyes G, Toledo-Rojas R, Torres-de Rueda Á, Sola-Moyano E, Blanca-Martos L, Fuentes-Sánchez L, Martínez-Esteban MD, Díez-de los Ríos MJ, Bailén-García A, González-Molina M, García-González I.
    Nefrologia; 2012 Oct; 32(1):35-43. PubMed ID: 22294003
    [Abstract] [Full Text] [Related]

  • 7. [Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].
    Rosa J, Sydor A, Jurczyszyn A, Zabawa-Hołyś S, Nowak J, Czapkowicz-Gryszkiewicz L, Sułowicz W.
    Przegl Lek; 2010 Oct; 67(7):547-50. PubMed ID: 21387773
    [Abstract] [Full Text] [Related]

  • 8. Management options for cast nephropathy in multiple myeloma.
    Cockwell P, Hutchison CA.
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):550-5. PubMed ID: 20827195
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.
    Ecotière L, Thierry A, Debiais-Delpech C, Chevret S, Javaugue V, Desport E, Belmouaz S, Quellard N, Kaaki S, Goujon JM, Fermand JP, Touchard G, Bridoux F.
    Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418
    [Abstract] [Full Text] [Related]

  • 10. Multiple myeloma--presenting as acute kidney injury.
    Prakash J, Niwas SS, Parekh A, Vohra R, Wani IA, Sharma N, Usha.
    J Assoc Physicians India; 2009 Jan; 57():23-6. PubMed ID: 19753754
    [Abstract] [Full Text] [Related]

  • 11. Successful use of combined high cut-off haemodialysis and bortezomib for acute kidney injury associated with myeloma cast nephropathy.
    Ward F, Dunne O, Crotty TB, Fennelly D, Watson A, Holian J.
    Ir Med J; 2012 May; 105(5):148-9. PubMed ID: 22803494
    [Abstract] [Full Text] [Related]

  • 12. Current approach to diagnosis and management of acute renal failure in myeloma patients.
    Leung N, Behrens J.
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):297-302. PubMed ID: 22920640
    [Abstract] [Full Text] [Related]

  • 13. Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trial.
    Bridoux F, Fermand JP.
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):333-41. PubMed ID: 22920644
    [Abstract] [Full Text] [Related]

  • 14. Nonsecretory multiple myeloma - a rare case of acute renal failure.
    Adamidis KN, Charitaki EE, Christodoulidou C, Tasidou A, Hadjiconstantinou V.
    Clin Nephrol; 2010 Oct; 74(4):311-4. PubMed ID: 20875385
    [Abstract] [Full Text] [Related]

  • 15. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.
    Yadav P, Hutchison CA, Basnayake K, Stringer S, Jesky M, Fifer L, Snell K, Pinney J, Drayson MT, Cook M, Cockwell P.
    Eur J Haematol; 2016 Jun; 96(6):610-7. PubMed ID: 26248588
    [Abstract] [Full Text] [Related]

  • 16. Renal histological lesions and clinical syndromes in multiple myeloma. Renal Immunopathology Group.
    Pasquali S, Zucchelli P, Casanova S, Cagnoli L, Confalonieri R, Pozzi C, Banfi G, Lupo A, Bertani T.
    Clin Nephrol; 1987 May; 27(5):222-8. PubMed ID: 3109793
    [Abstract] [Full Text] [Related]

  • 17. Recovery of kidney function following delayed use of Theralite™ dialyzer in a patient with myeloma cast nephropathy.
    Dahal K, Shastri S, Narayanasami U, Bijol V, Rider K, Strom JA, Jaber BL.
    Clin Nephrol; 2013 Apr; 79(4):318-22. PubMed ID: 22541683
    [Abstract] [Full Text] [Related]

  • 18. Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure.
    Kelly KJ, Dominguez JH.
    Am J Nephrol; 2010 Apr; 32(5):469-75. PubMed ID: 20956853
    [Abstract] [Full Text] [Related]

  • 19. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.
    Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR.
    J Am Soc Nephrol; 2007 Mar; 18(3):886-95. PubMed ID: 17229909
    [Abstract] [Full Text] [Related]

  • 20. [Improved prognosis in light chain nephropathy due to multiple myeloma].
    Juul JS, Larsen T, Marcussen N, Pedersen EB.
    Ugeskr Laeger; 2012 Apr 23; 174(17):1159-60. PubMed ID: 22533933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.